Effects of desmethylclozapine on Fos protein expression in the forebrain: In vivo biological activity of the clozapine metabolite

Neuropsychopharmacology

Volumn 19, Issue 1, 1998, Pages 99-103

  Young, Cheryl D ^a   Meltzer, Herbert Y ^a   Deutch, Ariel Y ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic drugs; Immediate early gene; Nucleus accumbens; Prefrontal cortex; Schizophrenia; Striatum

Indexed keywords

CLOZAPINE; NORCLOZAPINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG METABOLISM; IMMEDIATE EARLY GENE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOPHARMACOLOGY; RAT; SCHIZOPHRENIA; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BLOTTING, WESTERN; CLOZAPINE; MALE; PROSENCEPHALON; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031781299     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00203-0     Document Type: Article

References (35)

1. Alvir JM, Lieberman JA, Safferman AZ, Schwimmer JL, Schaaf JA Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med. 329:1993;162-167.
2. Baldessarini RJ, Frankenburg FR Clozapine. A novel antipsychotic drug N Engl J Med. 324:1991;746-754.
3. Baldessarini FJ, Centorrino F, Flood JG, Volpicelli SA, Huston-Lyons D, Cohen BM Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology. 9:1993;117-124.
4. Centorrino F, Baldessarini RJ, Kando JC, Frankenburg FR, Volpicelli SA, Flood JG Clozapine and metabolites. concentrations in serum and clinical findings during treatment of chronically psychotic patients J Clin Psychopharmacol. 14:1994;119-125.
5. Cullinan WE, Herman JP, Battaglia DF, Akil H, Watson SJ Pattern and time course immediate-early gene expression in rat brain following acute stress. Neuroscience. 64:1995;477-505.
6. Deutch AY The mechanisms of action of antipsychotic drugs as revealed by immediate-early gene expression. Csernansky JG Antipsychotics (Handbook of Exp Pharmacol, vol 120). 1996;117-161 Springer, Berlin.
7. Deutch AY, Duman RS The effects of antipsychotic drugs on prefrontal cortical Fos expression. Cellular localization and pharmacological characterization Neuroscience. 70:1996;377-389.
8. Deutch AY, Moghaddam B, Innis R, Krystal JH, Aghajanian GK, Bunney BS, Charney DS Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia Schizophr Res. 4:1991;121-156.
9. Deutch AY, Lee MC, Iadorola MJ Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression. The nucleus accumbens shell as a locus of antipsychotic action Mol Cell Neurosci. 3:1992;332-341.
10. Deutch AY, Öngür D, Duman RS Fos induction by antipsychotic drugs in the medial thalamus. A novel locus of antipsychotic drug action Neuroscience. 66:1995;337-346.
11. 2 dopamine antagonists on Fos protein expression in the striatal complex and temporal cortices of the non-human primate. Synapse. 23:1996;182-191.
12. DeVane CL Brief comparison of the pharmacokinetics and pharmacodynamics of the traditional and newer antipsychotic drugs. Am J Health-System Pharm. 52(Suppl):1995;S15-S18.
13. Farde L, Nordstrom AL, Wiesel FA, Pauli S, Halldin C, Sedvall G Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Arch Gen Psychiatry. 49:1992;538-544.
14. Fatemi SH, Meltzer HY, Roth BL Atypical antipsychotic drugs. Clinical and preclinical studies Csernansky JG Antipsychotics (Handbook of Exp Pharmacol, vol 120). 1996;77-115 Springer, Berlin.
15. Fischer V, Vogels B, Maurer G, Tynes RE The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. J Pharmacol Exp Ther. 260:1992;1355-1360.
16. Gershon SL, Arce C, Meltzer HY N-desmethylclozapine. A clozapine metabolite that suppresses haemopoiesis Br J Haematol. 86:1994;555-561.
17. Guo H, Klitenick MA, Tham CS, Fibiger HC Receptor mechanisms mediating clozapine-induced c-fos expression in the forebrain. Neuroscience. 65:1995;747-756.
18. Hall H, Halldin C, Nyberg S, Farde L, Sedvall G Effect of clozapine and risperidon on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. Eur Neuropsychopharmacol. 5:1995;19-25.
19. Hasegawa M, Cola PA, Meltzer HY Plasma clozapine and desmethylclozapine in clozapine-induced agranulocytosis. Neuropsychopharmacology. 11:1994;45-47.
20. Ikemoto K, Satoh K, Maeda T, Fibiger HC Neurochemical heterogeneity of the primate nucleus accumbens. Exp Brain Res. 104:1995;177-190.
21. Jann MW, Lam YW, Chang WH Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration. Arch Int Pharmacodyn Ther. 328:1994;243-250.
22. Kane JM, Honigfeld G, Singer J, Meltzer H, and the Clozaril Collaborative Study Group (1988): Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychiatry 45:789-796.
23. Karlsson P, Smith L, Farde L, Harnryd C, Sedvall G, Wiesel FA Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist CH39166 in acutely ill schizophrenic patients. Psychopharmacology. 121:1995;309-316.
24. 1c receptor antagonists. Eur J Pharmacol (Mol Pharmacol). 245:1993;179-182.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem. 193:1951;265-275.
26. Meltzer HY, Ranjan R Efficacy of novel antipsychotic drugs in treatment-refractory schizophrenia. Csernansky JG Antipsychotics (Handbook of Exp Pharmacol, vol 120). 1996;333-357 Springer, Berlin.
27. i values. J Pharmacol Exp Ther. 251:1989;238-246.
28. Nguyen TV, Kasofsky B, Birnbaum R, Cohen BM, Hyman SE Differential expression of c-fos and Zif 268 in rat striatum following haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA. 89:1992;4270-4274.
29. Nordstrom AL, Farde L, Nybert S, Karlsson P, Halldin C, Sedvall G D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration. A PET study of schizophrenic subjects Am J Psychiatry. 152:1995;1444-1449.
30. Pirmohamed M, Williams D, Madden S, Templeton E, Park BK Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther. 272:1995;984-990.
31. Piscitelli SC, Frazier JA, McKenna K, Albus KE, Grothe DR, Gordon CT, Rapoport JL Plasma clozapine and haloperidol concentrations in adolescents with childhood onset schizophrenia. association with response J Clin Psychiatry. 55(Suppl B):1994;94-97.
32. Quinn JP, Takimoto M, Iadarola MJ, Holbrook N, Levens D Distinct factors bind the AP-1 consensus sites in gibbon ape leukemia virus and simian virus 40 enhancers. J Virol. 63:1989;1737-1742.
33. Robertson GS, Fibiger HC Neuroleptics increase c-fos expression in the forebrain. contrasting effects of haloperidol and clozapine Neuroscience. 46:1992;315-328.
34. Robertson GS, Matsumura H, Fibiger HC Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther. 271:1994;1058-1066.
35. Squires RF, Saederup E A review of evidence for GABAergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses. More support for a continuum hypothesis of "functional" psychosis Neurochem Res. 16:1991;1099-1111.